SCHEMBL17275010

SCHEMBL17275010

CCCCOc1c(C(N)=O)ccc(OC)c1Oc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
MAPT P10636 4/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NR1I2 O75469 1/20 0.47
CHRM2 P08172 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADRA2A P08913 1/20 0.47
OPRK1 P41145 1/20 0.47
HTR2B P41595 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
CTNNB1 P35222 1/20 0.47
LTA4H P09960 2/20 0.46
CNR2 P34972 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
PARP10 Q53GL7 3/20 0.42
PARP15 Q460N3 2/20 0.42
PARP14 Q460N5 1/20 0.42
PPARG P37231 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17275067 0.86 LMNA (0.43) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL19471202 0.84 LTA4H (0.47) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL17275059 0.81 MAPK10 (0.46) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL19471187 0.80 CTNNB1 (0.44) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL17275012 0.79 LMNA (0.57) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL17275008 0.76 LMNA (0.60) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL11580782 0.76 TSHR (0.54) LMNAMAPTMEN1KMT2ACYP3A4
SCHEMBL15728128 0.73 THRA (0.50) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL29720413 0.73 MEN1 (0.64) LMNAMAPTMEN1KMT2ANR1I2
SCHEMBL28440618 0.73 MEN1 (0.64) LMNAMAPTMEN1KMT2ANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170305943-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS TAXIS PHARMACEUTICALS, INC. (US) 2017-10-26 US disclosed
WO-2015179697-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS TAXIS PHARMACEUTICALS, INC. (US) 2015-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305943-A1 COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS ELANE, MMP8, NISCH LMNA 3135/4885MAPT 4098/4885MEN1 3285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.